HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of typical, atypical, and no antipsychotic drugs on visual contrast detection in schizophrenia.

AbstractOBJECTIVE:
Visual contrast detection has been reported in some studies to be normal in schizophrenia patients, but in other studies impairments have been reported. Because contrast detection in the visual processing system is mediated by dopamine, and because the pharmacotherapy of schizophrenia involves blocking dopamine postsynaptic receptor sites, the authors investigated the effects of dopamine-blocking antipsychotic drugs on visual contrast detection in schizophrenia.
METHOD:
Visual contrast detection thresholds were measured in healthy subjects and schizophrenia patients receiving typical and atypical antipsychotic drugs; a two-alternative, forced-choice psychophysical method was used. Also included were six patients receiving no antipsychotic treatment as well as clinically unaffected first-degree relatives of the schizophrenia patients.
RESULTS:
Patients receiving atypical antipsychotic drugs showed unimpaired visual contrast detection, those given typical antipsychotic drugs exhibited higher visual contrast detection thresholds, and the unmedicated schizophrenic patients showed visual contrast detection thresholds significantly below those of healthy subjects.
CONCLUSIONS:
Dopamine modulation via D(2) receptor blockade affects sensory processes in schizophrenia, shifting visual contrast detection from hypersensitivity in the unmedicated state to normal and even to hyposensitive levels. Thus, antipsychotic drug treatment may account for the inconsistent reports concerning visual contrast detection in schizophrenia.
AuthorsYue Chen, Deborah L Levy, Summer Sheremata, Ken Nakayama, Steven Matthysse, Philip S Holzman
JournalThe American journal of psychiatry (Am J Psychiatry) Vol. 160 Issue 10 Pg. 1795-801 (Oct 2003) ISSN: 0002-953X [Print] United States
PMID14514493 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antipsychotic Agents
  • Dopamine Agents
Topics
  • Adult
  • Antipsychotic Agents (administration & dosage, pharmacology)
  • Contrast Sensitivity (drug effects)
  • Dopamine Agents (administration & dosage, pharmacology)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Schizophrenia (drug therapy, physiopathology)
  • Schizophrenic Psychology

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: